PhotoCure ASA (OSL:PHO) EPS (Basic): kr3.17 (TTM As of Mar. 2026)


OSL:PHO PhotoCure ASA OSL:PHO
77 GF Score
Price kr59.80
GF Value kr74.44
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is PhotoCure ASA EPS (Basic)?

PhotoCure ASA OSL:PHO -0.33% 77 EPS (Basic) is kr3.17 as of Mar. 2026. GuruFocus rates OSL:PHO with a GF Score™ of 77/100 and a GF Value™ of kr74.44 (Modestly Undervalued). The stock has 1 warning sign investors should review.

PhotoCure ASA's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was kr3.14. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was kr3.17.

PhotoCure ASA's EPS (Diluted) for the three months ended in Mar. 2026 was kr3.12. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr3.15.

PhotoCure ASA's EPS without NRI for the three months ended in Mar. 2026 was kr3.12. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 3.15.

During the past 12 months, PhotoCure ASA's average EPS without NRIGrowth Rate was 15650.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 71.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, PhotoCure ASA's highest 3-Year average EPS without NRI Growth Rate was 71.70% per year. The lowest was -22.30% per year. And the median was 21.30% per year.

PhotoCure ASA  (OSL:PHO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

PhotoCure ASA EPS (Basic) Related Terms

PhotoCure ASA EPS (Basic) Historical Data

* Premium members only.

The historical data trend for PhotoCure ASA's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhotoCure ASA EPS (Basic) Chart

PhotoCure ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.15 -2.66 0.04 -0.19 -0.06

PhotoCure ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 0.18 0.15 -0.30 3.14
OSL:PHO
77GF Score
PhotoCure ASA OSL:PHO
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhotoCure ASA EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

PhotoCure ASA's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.517-0)/26.661
=-0.06

PhotoCure ASA's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(83.419-0)/26.607
=3.14

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of kr3.17 mean?
PhotoCure ASA (OSL:PHO) has a EPS (Basic) of kr3.17 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on PhotoCure ASA and its competitors.
Is PhotoCure ASA's EPS (Basic) too high?
PhotoCure ASA's current EPS (Basic) is kr3.17. Overall, PhotoCure ASA has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PhotoCure ASA's EPS (Basic) compare to ZTS and UTHR?
PhotoCure ASA's EPS (Basic) of kr3.17 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on PhotoCure ASA and its competitors. PhotoCure ASA's current EPS (Basic) is kr3.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhotoCure ASA stock overvalued right now?
Based on GuruFocus' analysis, PhotoCure ASA (OSL:PHO) is currently considered Modestly Undervalued. The stock's GF Value™ is kr74.44, compared to a current price of kr59.80 — trading 19.7% below its estimated fair value. The current EPS (Basic) is kr3.17. PhotoCure ASA's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For PhotoCure ASA (OSL:PHO), the current EPS (Basic) is kr3.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhotoCure ASA (OSL:PHO) Overvalued in 2026?

Based on GuruFocus' analysis, PhotoCure ASA stock appears to be undervalued. The current stock price of kr59.80 is trading 19.7% below its estimated GF Value™ of kr74.44. GuruFocus considers PhotoCure ASA to be Modestly Undervalued.

Key valuation signals for OSL:PHO:

  • EPS (Basic): kr3.17
  • GF Value™: kr74.44 vs. price of kr59.80 (19.7% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the OSL:PHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PhotoCure ASA Business Description

Address Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.
77GF Score

Get the complete analysis for OSL:PHO

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr59.80
Price
kr74.44
GF Value